940 related articles for article (PubMed ID: 32630835)
1. Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing.
Naeem M; Majeed S; Hoque MZ; Ahmad I
Cells; 2020 Jul; 9(7):. PubMed ID: 32630835
[TBL] [Abstract][Full Text] [Related]
2. Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants.
Hajiahmadi Z; Movahedi A; Wei H; Li D; Orooji Y; Ruan H; Zhuge Q
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366028
[TBL] [Abstract][Full Text] [Related]
3. CRISPR-Cas systems: ushering in the new genome editing era.
Perez Rojo F; Nyman RKM; Johnson AAT; Navarro MP; Ryan MH; Erskine W; Kaur P
Bioengineered; 2018; 9(1):214-221. PubMed ID: 29968520
[TBL] [Abstract][Full Text] [Related]
4. Evaluating and Enhancing Target Specificity of Gene-Editing Nucleases and Deaminases.
Kim D; Luk K; Wolfe SA; Kim JS
Annu Rev Biochem; 2019 Jun; 88():191-220. PubMed ID: 30883196
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
6. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes.
Jacobi AM; Rettig GR; Turk R; Collingwood MA; Zeiner SA; Quadros RM; Harms DW; Bonthuis PJ; Gregg C; Ohtsuka M; Gurumurthy CB; Behlke MA
Methods; 2017 May; 121-122():16-28. PubMed ID: 28351759
[TBL] [Abstract][Full Text] [Related]
7. Genome editing via delivery of Cas9 ribonucleoprotein.
DeWitt MA; Corn JE; Carroll D
Methods; 2017 May; 121-122():9-15. PubMed ID: 28410976
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas9 in genome editing: Its function and medical applications.
Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
[TBL] [Abstract][Full Text] [Related]
9. Optimization of genome editing through CRISPR-Cas9 engineering.
Zhang JH; Adikaram P; Pandey M; Genis A; Simonds WF
Bioengineered; 2016 Apr; 7(3):166-74. PubMed ID: 27340770
[TBL] [Abstract][Full Text] [Related]
10. [CRISPR/CAS9, the King of Genome Editing Tools].
Bannikov AV; Lavrov AV
Mol Biol (Mosk); 2017; 51(4):582-594. PubMed ID: 28900076
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of Cas9 and single-guided RNAs in
Qiao J; Li W; Lin S; Sun W; Ma L; Liu Y
Commun Biol; 2019; 2():161. PubMed ID: 31069270
[TBL] [Abstract][Full Text] [Related]
12. Highly efficient DNA-free gene disruption in the agricultural pest Ceratitis capitata by CRISPR-Cas9 ribonucleoprotein complexes.
Meccariello A; Monti SM; Romanelli A; Colonna R; Primo P; Inghilterra MG; Del Corsano G; Ramaglia A; Iazzetti G; Chiarore A; Patti F; Heinze SD; Salvemini M; Lindsay H; Chiavacci E; Burger A; Robinson MD; Mosimann C; Bopp D; Saccone G
Sci Rep; 2017 Aug; 7(1):10061. PubMed ID: 28855635
[TBL] [Abstract][Full Text] [Related]
13. Application of the CRISPR/Cas system for genome editing in microalgae.
Zhang YT; Jiang JY; Shi TQ; Sun XM; Zhao QY; Huang H; Ren LJ
Appl Microbiol Biotechnol; 2019 Apr; 103(8):3239-3248. PubMed ID: 30877356
[TBL] [Abstract][Full Text] [Related]
14. Targeted genome editing in human cells using CRISPR/Cas nucleases and truncated guide RNAs.
Fu Y; Reyon D; Joung JK
Methods Enzymol; 2014; 546():21-45. PubMed ID: 25398334
[TBL] [Abstract][Full Text] [Related]
15. Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Wilbie D; Walther J; Mastrobattista E
Acc Chem Res; 2019 Jun; 52(6):1555-1564. PubMed ID: 31099553
[TBL] [Abstract][Full Text] [Related]
16. Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant.
Tran MTN; Khalid MKNM; Pébay A; Cook AL; Liang HH; Wong RCB; Craig JE; Liu GS; Hung SS; Hewitt AW
Mol Vis; 2019; 25():174-182. PubMed ID: 30996586
[TBL] [Abstract][Full Text] [Related]
17. Versatile modification of the CRISPR/Cas9 ribonucleoprotein system to facilitate in vivo application.
Sun B; Chen H; Gao X
J Control Release; 2021 Sep; 337():698-717. PubMed ID: 34364918
[TBL] [Abstract][Full Text] [Related]
18. Advances in detecting and reducing off-target effects generated by CRISPR-mediated genome editing.
Li J; Hong S; Chen W; Zuo E; Yang H
J Genet Genomics; 2019 Nov; 46(11):513-521. PubMed ID: 31911131
[TBL] [Abstract][Full Text] [Related]
19. Shooting the messenger: RNA-targetting CRISPR-Cas systems.
Zhu Y; Klompe SE; Vlot M; van der Oost J; Staals RHJ
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29748239
[TBL] [Abstract][Full Text] [Related]
20. PEG-Delivered CRISPR-Cas9 Ribonucleoproteins System for Gene-Editing Screening of Maize Protoplasts.
Sant'Ana RRA; Caprestano CA; Nodari RO; Agapito-Tenfen SZ
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32887261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
